EuropeSouth AsiaAsia PacificAmericasMiddle EastAfricaBBC HomepageWorld ServiceEducation
News image
News image
News image
News imageNews image
News image
Front Page
News image
World
News image
UK
News image
UK Politics
News image
Business
News image
Sci/Tech
News image
Health
News image
Education
News image
Sport
News image
Entertainment
News image
Talking Point
News image
In Depth
News image
On Air
News image
Archive
News image
News image
News image
Feedback
Low Graphics
Help
News imageNews imageNews image
News imageMonday, November 1, 1999 Published at 06:33 GMT
News image
News image
Health
News image
Mass meningitis vaccination programme begins
News image
The vaccine could prevent many deaths from the brain disease
News image
The government has officially launched its meningitis vaccination programme, first targeting 15 to 17-year-olds and then babies.

Children around the UK are to become the first in the world to take part in routine vaccinations against the C strain of meningitis.

The meningitis file
The vaccine has already been tested on more than 4,000 British children and 21,000 children outside the UK.

The mass immunisation programme has also been piloted in Ironville, South Derbyshire, which has been particularly affected by the brain disease.


News imageNews image
The BBC's Fergus Walsh: "One of the UK's biggest immunisation programmes"
Announcing the move in the House of Commons in July, then Health Secretary Frank Dobson said the programme will cut by half the number of outbreaks and deaths from the disease.

The new vaccine will initially be targeted at those most at risk:

  • Young people aged 15, 16 and 17
  • Babies aged two, three and four months when they get their routine diptheria, tetanus, whooping cough, polio and Hib vaccine
  • Children aged 13 months when they get their first measles, mumps and rubella vaccine
  • Children aged over four months and under one year who will be specifically recalled

As more supplies become available children aged one to five will be the next to be vaccinated early next year, followed by children in other age groups.

The priority groups have been agreed by the Joint Committee on Vaccination and Immunisation, the National Meningitis Trust and the Meningitis Research Foundation.

Killer disease

Last year, the meningococcal group C infection affected more than 1,500 people and killed 150 of them, mainly children and young people.


News imageNews image
Professor Liam Donaldson, Chief Medical Officer, speaking to the BBC's Today programme
About one in three of all British cases of the brain disease are caused by the C strain.

At least one in 10 of those who contracts meningitis C is killed by the disease.

The vaccine has been developed by three companies.

However, parents will have to remain alert for the symptoms of meningitis even when their child has been vaccinated, as there is still no vaccine against Group B meningococcal infection, although these cases tend to be more isolated in the UK.


News imageNews image
GP, Dr Rosemary Leonard talking to the BBC's Today programme
The Meningitis Research Foundation says the immunisation programme will save lives since it is "much more effective than the one currently available".


News image


Advanced options | Search tips


News image
News image
News imageBack to top | BBC News Home | BBC Homepage |
News image

News imageNews imageNews image
Health Contents
News image
News imageBackground Briefings
News imageMedical notes
News imageNews image
Relevant Stories
News image
01 Nov 99�|�Northern Ireland
Doctors frustrated over vaccine scarcity
News image
20 Jul 99�|�Health
Mass vaccine targets meningitis
News image
12 Feb 99�|�Medical notes
The argument for mass meningitis vaccinations
News image
10 Feb 99�|�Medical notes
Meningitis: Preventive measures
News image

News image
News image
News image
News imageInternet Links
News image
News imageNews image
National Meningitis Trust
News image
Meningitis Research Foundation
News image
Department of Health
News image
News imageNews image
The BBC is not responsible for the content of external internet sites.

News image
News image
News image
News imageIn this section
News image
Disability in depth
News image
Spotlight: Bristol inquiry
News image
Antibiotics: A fading wonder
News image
Mental health: An overview
News image
Alternative medicine: A growth industry
News image
The meningitis files
News image
Long-term care: A special report
News image
Aids up close
News image
From cradle to grave
News image
NHS reforms: A guide
News image
NHS Performance 1999
News image
From Special Report
NHS in crisis: Special report
News image
British Medical Association conference '99
News image
Royal College of Nursing conference '99
News image

News image
News image
News image